SCHEMBL5873202

SCHEMBL5873202

O=C(c1ccc(I)cc1)C(Br)C(Br)c1ccc(Br)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.56
CNR1 P21554 1/20 0.45
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
TPMT P51580 1/20 0.39
CYP1A2 P05177 2/20 0.39
ALDH1A1 P00352 1/20 0.39
CA1 P00915 4/20 0.38
CA2 P00918 4/20 0.38
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
PDPK1 O15530 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
OGG1 O15527 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5873189 0.91 CES2 (0.48) GSK3BCES2CES1CYP1A2ALDH1A1
SCHEMBL5873117 0.82 LMNA (0.50) CES2CES1CYP1A2ALDH1A1CA1
SCHEMBL28795688 0.82 MEN1 (0.50) CNR1CES2CES1CYP1A2ALDH1A1
SCHEMBL5319310 0.81 GSK3B (0.46) GSK3BCNR1CES2CES1ALDH1A1
SCHEMBL7734235 0.79 CES2 (0.56) GSK3BCES2CES1CYP1A2ALDH1A1
SCHEMBL1799408 0.78 PARP1 (0.41) CES2CES1CYP1A2ALDH1A1CA1
SCHEMBL1795647 0.75 PARP1 (0.49) GSK3BCYP1A2ALDH1A1KMT2AMEN1
SCHEMBL6789159 0.73 GSK3B (1.00) GSK3BTPMTCYP1A2ALDH1A1CA1
SCHEMBL8143209 0.73 LMNA (0.59) GSK3BCES2CES1TPMTCA1
SCHEMBL1796450 0.72 GSK3B (0.66) GSK3BCYP1A2ALDH1A1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067702-B2 Process for preparing vinyl substituted beta-diketones THE JOHNS HOPKINS UNIVERSITY (US) 2006-06-27 US disclosed
US-20060069288-A1 Process for preparing vinyl substituted beta-diketones THE JOHNS HOPKINS UNIVERSITY 2006-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069288-A1 Process for preparing vinyl substituted beta-diketones VRK1, VRK2, DEK GSK3B 528/4885CNR1 4081/4885CES2 2479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.